Title
Category
Credits
Event date
Cost
Tackling Medical Misinformation: Empowering Health Care Professionals to Combat Misinformation and Promote Accurate Health Information
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
The potential consequences of medical misinformation on public health, such as the spread of vaccine hesitancy, will be discussed, and participants will come away empowered with additional strategies and tools to more effectively address medical misinformation and promote accurate health information to patients and the wider community.
Creating Space for Complex Conversations with Patients Experiencing Life-Changing Illnesses
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Caring for patients with complex medical conditions can be emotionally challenging for health care providers, particularly when difficult conversations need to be had with patients and their loved ones. This session will explore complex grief, its symptoms, and how health care professionals can recognize it in themselves and their patients, as well as provide strategies for managing grief and supporting patients and families.
Optimizing Patient-Reported Outcomes for Enhanced Quality, Experience and Decision-Making in Health Care
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Patient-reported outcomes (PRO) are crucial in evaluating the impact of health care professionals, teams, and systems on patients’ health, quality of life, and treatment outcomes. By consistently tracking PRO scores, health care organizations can pinpoint areas of excellence and opportunities for improvement, as well as compare the effectiveness of different treatment options. This presentation will explore the benefits of PRO measures in health care and provide insights on how to seamlessly integrate these measures into clinical practice. Strategies for interpreting and utilizing PRO data to improve health care quality will also be highlighted.
CRISPR-Based Therapies for Genetic Blood Disorders
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join this session to explore updates in genetic therapy for two prevalent hemaglobinopathies: sickle cell disease and beta thalassemia.
Chronic Kidney Disease: Advancing Strategies to Prevent Progression
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Chronic kidney disease (CKD), typically caused by diabetes and hypertension, affects 15% of US adults and continues to increase with the rising prevalence of these conditions. Increased health care utilization and high morbidity/mortality rates are associated with the progression of CKD to kidney failure with comorbid cardiovascular disease, anemia and bone disease. This session will examine the current state of care for CKD, including recent advancements and interventions that can slow CKD progression and preserve kidney function and strategies to optimize care pathways for managing CKD and its common comorbidities.
New and Emerging Approaches to Diabetes Management
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will outline the current state of diabetes therapy and review recent data regarding the effectiveness of remission-related approaches. It will also discuss available and emerging AI applications that can assist patients with glycemic control.
The Battle Against Alzheimer’s Disease: New Advancements, Treatments and Hope
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Alzheimer’s disease (AD) is a pressing public health crisis, affecting more than 6 million people in the U.S. and increasing in prevalence with the aging population. Join us in exploring the latest advances in AD diagnosis and management, including biomarkers, imaging techniques and cognitive assessments. Emerging pharmacological therapies that target the underlying disease and novel approaches to optimizing patient care will be highlighted.
Exploring Opioid Crisis Dynamics: New Perspectives and Strategies
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will focus on enhancing our understanding of the current opioid crisis and will explore new angles and address current concerns, including the use of over-the-counter intranasal naloxone, the evolving landscape of opioids with a focus on fentanyl, the intersection between suicide and opioid overdoses, the significance of the new 988 helpline in the crisis, and the viability of home-based detox startups. Strategies to effectively address the ongoing challenges of the opioid crisis will be discussed.
Medical Mysteries Revealed: Unraveling the Secrets of Rare and Undiagnosed Diseases
  • Disease management
  • Rare diseases
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 CDR - Dietitians
  • 1.25 ASWB - Social Workers
$0.00
Millions of people around the world suffer from rare and undiagnosed diseases, often leading to years of frustration, uncertainty, and distress. This session will explore the latest approaches and tools for diagnosing and managing rare diseases. It will delve into cutting-edge genetic-sequencing technologies and advanced data analytics that can assist and guide diagnosis. Participants will also learn about interdisciplinary teams and patient advocacy and the impact they have on solving these complex medical problems.
Helping Little Hearts: Updates in Transplantation for Congenital Heart Disease
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Pediatric patients referred for heart transplant (HTx) due to congenital heart disease (CHD) are considered high-risk due to their disease complexity and their specific peritransplant surgical risks. However, there has been great improvement in pediatric CHD outcomes treated with HTx- and surgical therapies, especially with the use of ventricular assist devices (VADs). This session will review the current state of HTx for pediatric CHD, addressing issues such as mortality risk factors, waitlist mortality, mechanical-support options, and immunosuppression and antibody-mediated rejection. It will also discuss key issues for this population, including psychosocial challenges, rehabilitation goals and future expectations regarding functional outcomes.

Pages